Supplementary Table S2 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia
crossref(2023)
摘要
Class I phosphotyrosine (pY) sites of the "Tyrosine Kinases" enriched either in T-ALL (ALL-8, ALL-31) and B-ALL (ALL-17, ALL-19)
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要